H3 receptor — Drug Target

All drugs that target H3 receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Histamine H3 receptor antagonist

Phase 3 pipeline (4)

• BF2.649 · Bioprojet · Histamine H3 receptor antagonist · Neurology
  BF2.649 is a histamine H3 receptor antagonist that increases histamine signaling in the brain to promote wakefulness and cognitive function.
• BF2.649 (pitolisant) · Bioprojet · Histamine H3 receptor antagonist · Neurology
  Pitolisant is a selective histamine H3 receptor antagonist that increases histamine release in the brain to promote wakefulness.
• Double-blind pitolisant · Harmony Biosciences Management, Inc. · Histamine H3 receptor antagonist · Neurology
  Pitolisant is a selective histamine H3 receptor antagonist that increases wakefulness by blocking inhibitory histamine signaling in the brain.
• Pitolisant tablet · Harmony Biosciences Management, Inc. · Histamine H3 receptor antagonist · Neurology
  Pitolisant is a selective histamine H3 receptor antagonist that increases histamine release in the brain to promote wakefulness.